Skip to main content
NCBI home page
Gut logoLink to Gut
. 1995 Feb;36(2):255–258. doi: 10.1136/gut.36.2.255

1,25-Dihydroxyvitamin D3 and retinoid X receptor expression in human colorectal neoplasms.

K F Kane 1, M J Langman 1, G R Williams 1
PMCID: PMC1382413  PMID: 7883226

Abstract

Epidemiological studies suggest that 1,25-dihydroxyvitamin D3 (D3) protects against colorectal carcinogenesis. Animal and in vitro studies show an antiproliferative effect of D3 in a variety of tumours including those of large bowel origin. D3 actions are mediated by D3 receptors (VDR) alone or by VDR in conjunction with retinoid X receptors (RXRs) in all D3 responsive tissues. The expression of mRNAs encoding VDR and RXRs in normal and malignant human colorectum was determined. Full length VDR (4.6 kB), RXR alpha (5.5 kB), and RXR gamma (3.5 and 7 kB) mRNAs were expressed in all tissues, but RXR beta mRNA was not expressed in any. VDR expression was reduced in 12 carcinomas relative to paired normal mucosa, and RXR alpha expression was reduced in nine. There was no correlation between VDR or RXR alpha expression and the site, grade of differentiation, or Dukes's staging of the tumour. The finding of persistent VDR and RXR coexpression in all colorectal tumours provides a rational basis for exploring a role for D3 in the treatment of colorectal malignancy.

Full text

PDF
255

Images in this article

256Figure 1
on p.256
257Figure 2
on p.257

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Arbour N. C., Prahl J. M., DeLuca H. F. Stabilization of the vitamin D receptor in rat osteosarcoma cells through the action of 1,25-dihydroxyvitamin D3. Mol Endocrinol. 1993 Oct;7(10):1307–1312. doi: 10.1210/mend.7.10.8264662. [DOI] [PubMed] [Google Scholar]
  2. Baker A. R., McDonnell D. P., Hughes M., Crisp T. M., Mangelsdorf D. J., Haussler M. R., Pike J. W., Shine J., O'Malley B. W. Cloning and expression of full-length cDNA encoding human vitamin D receptor. Proc Natl Acad Sci U S A. 1988 May;85(10):3294–3298. doi: 10.1073/pnas.85.10.3294. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Berger U., Wilson P., McClelland R. A., Colston K., Haussler M. R., Pike J. W., Coombes R. C. Immunocytochemical detection of 1,25-dihydroxyvitamin D receptors in normal human tissues. J Clin Endocrinol Metab. 1988 Sep;67(3):607–613. doi: 10.1210/jcem-67-3-607. [DOI] [PubMed] [Google Scholar]
  4. Bikle D. D. Clinical counterpoint: vitamin D: new actions, new analogs, new therapeutic potential. Endocr Rev. 1992 Nov;13(4):765–784. doi: 10.1210/edrv-13-4-765. [DOI] [PubMed] [Google Scholar]
  5. Binderup L., Bramm E. Effects of a novel vitamin D analogue MC903 on cell proliferation and differentiation in vitro and on calcium metabolism in vivo. Biochem Pharmacol. 1988 Mar 1;37(5):889–895. doi: 10.1016/0006-2952(88)90177-3. [DOI] [PubMed] [Google Scholar]
  6. Binderup L., Latini S., Binderup E., Bretting C., Calverley M., Hansen K. 20-epi-vitamin D3 analogues: a novel class of potent regulators of cell growth and immune responses. Biochem Pharmacol. 1991 Sep 27;42(8):1569–1575. doi: 10.1016/0006-2952(91)90426-6. [DOI] [PubMed] [Google Scholar]
  7. Brehier A., Thomasset M. Human colon cell line HT-29: characterisation of 1,25-dihydroxyvitamin D3 receptor and induction of differentiation by the hormone. J Steroid Biochem. 1988 Feb;29(2):265–270. doi: 10.1016/0022-4731(88)90275-0. [DOI] [PubMed] [Google Scholar]
  8. Carlberg C., Bendik I., Wyss A., Meier E., Sturzenbecker L. J., Grippo J. F., Hunziker W. Two nuclear signalling pathways for vitamin D. Nature. 1993 Feb 18;361(6413):657–660. doi: 10.1038/361657a0. [DOI] [PubMed] [Google Scholar]
  9. Colston K. W., Berger U., Coombes R. C. Possible role for vitamin D in controlling breast cancer cell proliferation. Lancet. 1989 Jan 28;1(8631):188–191. doi: 10.1016/s0140-6736(89)91204-x. [DOI] [PubMed] [Google Scholar]
  10. Colston K. W. New concepts in hormone receptor action. Lancet. 1993 Jul 10;342(8863):67–68. doi: 10.1016/0140-6736(93)91281-p. [DOI] [PubMed] [Google Scholar]
  11. Decarli A., Liati P., Negri E., Franceschi S., La Vecchia C. Vitamin A and other dietary factors in the etiology of esophageal cancer. Nutr Cancer. 1987;10(1-2):29–37. doi: 10.1080/01635588709513938. [DOI] [PubMed] [Google Scholar]
  12. Eisman J. A., Barkla D. H., Tutton P. J. Suppression of in vivo growth of human cancer solid tumor xenografts by 1,25-dihydroxyvitamin D3. Cancer Res. 1987 Jan 1;47(1):21–25. [PubMed] [Google Scholar]
  13. Evans R. M. The steroid and thyroid hormone receptor superfamily. Science. 1988 May 13;240(4854):889–895. doi: 10.1126/science.3283939. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Fuqua S. A., Fitzgerald S. D., Chamness G. C., Tandon A. K., McDonnell D. P., Nawaz Z., O'Malley B. W., McGuire W. L. Variant human breast tumor estrogen receptor with constitutive transcriptional activity. Cancer Res. 1991 Jan 1;51(1):105–109. [PubMed] [Google Scholar]
  15. Garland C. F., Comstock G. W., Garland F. C., Helsing K. J., Shaw E. K., Gorham E. D. Serum 25-hydroxyvitamin D and colon cancer: eight-year prospective study. Lancet. 1989 Nov 18;2(8673):1176–1178. doi: 10.1016/s0140-6736(89)91789-3. [DOI] [PubMed] [Google Scholar]
  16. Garland C., Shekelle R. B., Barrett-Connor E., Criqui M. H., Rossof A. H., Paul O. Dietary vitamin D and calcium and risk of colorectal cancer: a 19-year prospective study in men. Lancet. 1985 Feb 9;1(8424):307–309. doi: 10.1016/s0140-6736(85)91082-7. [DOI] [PubMed] [Google Scholar]
  17. Giuliano A. R., Franceschi R. T., Wood R. J. Characterization of the vitamin D receptor from the Caco-2 human colon carcinoma cell line: effect of cellular differentiation. Arch Biochem Biophys. 1991 Mar;285(2):261–269. doi: 10.1016/0003-9861(91)90358-p. [DOI] [PubMed] [Google Scholar]
  18. Green S. Nuclear hormone receptors. Promiscuous liaisons. Nature. 1993 Feb 18;361(6413):590–591. doi: 10.1038/361590a0. [DOI] [PubMed] [Google Scholar]
  19. Kliewer S. A., Umesono K., Mangelsdorf D. J., Evans R. M. Retinoid X receptor interacts with nuclear receptors in retinoic acid, thyroid hormone and vitamin D3 signalling. Nature. 1992 Jan 30;355(6359):446–449. doi: 10.1038/355446a0. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Lian J. B., Stein G. S., Bortell R., Owen T. A. Phenotype suppression: a postulated molecular mechanism for mediating the relationship of proliferation and differentiation by Fos/Jun interactions at AP-1 sites in steroid responsive promoter elements of tissue-specific genes. J Cell Biochem. 1991 Jan;45(1):9–14. doi: 10.1002/jcb.240450106. [DOI] [PubMed] [Google Scholar]
  21. Llor X., Jacoby R. F., Teng B. B., Davidson N. O., Sitrin M. D., Brasitus T. A. K-ras mutations in 1,2-dimethylhydrazine-induced colonic tumors: effects of supplemental dietary calcium and vitamin D deficiency. Cancer Res. 1991 Aug 15;51(16):4305–4309. [PubMed] [Google Scholar]
  22. MacDonald P. N., Dowd D. R., Nakajima S., Galligan M. A., Reeder M. C., Haussler C. A., Ozato K., Haussler M. R. Retinoid X receptors stimulate and 9-cis retinoic acid inhibits 1,25-dihydroxyvitamin D3-activated expression of the rat osteocalcin gene. Mol Cell Biol. 1993 Sep;13(9):5907–5917. doi: 10.1128/mcb.13.9.5907. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Mangelsdorf D. J., Borgmeyer U., Heyman R. A., Zhou J. Y., Ong E. S., Oro A. E., Kakizuka A., Evans R. M. Characterization of three RXR genes that mediate the action of 9-cis retinoic acid. Genes Dev. 1992 Mar;6(3):329–344. doi: 10.1101/gad.6.3.329. [DOI] [PubMed] [Google Scholar]
  24. Mangelsdorf D. J., Ong E. S., Dyck J. A., Evans R. M. Nuclear receptor that identifies a novel retinoic acid response pathway. Nature. 1990 May 17;345(6272):224–229. doi: 10.1038/345224a0. [DOI] [PubMed] [Google Scholar]
  25. Mano H., Ozawa T., Takeyama K., Yoshizawa Y., Kojima R., Kato S., Masushige S. Thyroid hormone affects the gene expression of retinoid X receptors in the adult rat. Biochem Biophys Res Commun. 1993 Mar 31;191(3):943–949. doi: 10.1006/bbrc.1993.1308. [DOI] [PubMed] [Google Scholar]
  26. Meggouh F., Lointier P., Saez S. Sex steroid and 1,25-dihydroxyvitamin D3 receptors in human colorectal adenocarcinoma and normal mucosa. Cancer Res. 1991 Feb 15;51(4):1227–1233. [PubMed] [Google Scholar]
  27. Ozono K., Sone T., Pike J. W. The genomic mechanism of action of 1,25-dihydroxyvitamin D3. J Bone Miner Res. 1991 Oct;6(10):1021–1027. doi: 10.1002/jbmr.5650061002. [DOI] [PubMed] [Google Scholar]
  28. Pence B. C., Buddingh F. Inhibition of dietary fat-promoted colon carcinogenesis in rats by supplemental calcium or vitamin D3. Carcinogenesis. 1988 Jan;9(1):187–190. doi: 10.1093/carcin/9.1.187. [DOI] [PubMed] [Google Scholar]
  29. Shabahang M., Buras R. R., Davoodi F., Schumaker L. M., Nauta R. J., Evans S. R. 1,25-Dihydroxyvitamin D3 receptor as a marker of human colon carcinoma cell line differentiation and growth inhibition. Cancer Res. 1993 Aug 15;53(16):3712–3718. [PubMed] [Google Scholar]
  30. Sitrin M. D., Halline A. G., Abrahams C., Brasitus T. A. Dietary calcium and vitamin D modulate 1,2-dimethylhydrazine-induced colonic carcinogenesis in the rat. Cancer Res. 1991 Oct 15;51(20):5608–5613. [PubMed] [Google Scholar]
  31. Tanaka Y., Bush K. K., Klauck T. M., Higgins P. J. Enhancement of butyrate-induced differentiation of HT-29 human colon carcinoma cells by 1,25-dihydroxyvitamin D3. Biochem Pharmacol. 1989 Nov 1;38(21):3859–3865. doi: 10.1016/0006-2952(89)90596-0. [DOI] [PubMed] [Google Scholar]
  32. Thomas M. G., Tebbutt S., Williamson R. C. Vitamin D and its metabolites inhibit cell proliferation in human rectal mucosa and a colon cancer cell line. Gut. 1992 Dec;33(12):1660–1663. doi: 10.1136/gut.33.12.1660. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Williams G. R., Brent G. A. Specificity of nuclear hormone receptor action: who conducts the orchestra? J Endocrinol. 1992 Nov;135(2):191–194. doi: 10.1677/joe.0.1350191. [DOI] [PubMed] [Google Scholar]
  34. Yu V. C., Delsert C., Andersen B., Holloway J. M., Devary O. V., När A. M., Kim S. Y., Boutin J. M., Glass C. K., Rosenfeld M. G. RXR beta: a coregulator that enhances binding of retinoic acid, thyroid hormone, and vitamin D receptors to their cognate response elements. Cell. 1991 Dec 20;67(6):1251–1266. doi: 10.1016/0092-8674(91)90301-e. [DOI] [PubMed] [Google Scholar]

Articles from Gut are provided here courtesy of BMJ Publishing Group

RESOURCES